PRP Creation Competitors

Vein Clinics of America (VCA) is the largest network of physicians in the country that provides specialized treatment for patients suffering from vein diseases. Patients also have access to enhanced procedures that utililze minimally invasive image guidance for the diagnosis and treatment of multiple diseased organ systems. Founded by a physician, the company opened its first office in 1981, in Chicago. Since then, VCA has expanded to include over 50 locations across 15 states. And we're growing! Our offices are staffed with physicians who have been specially trained in the diagnosis and treatment of vein disease. Their knowledge and published research have helped lead the way for today's safer and more effective, minimally invasive, treatment options. VCA has also opened several "enhanced offices" that are staffed by Interventional Radiologists and Vascular Surgeons. Those offices offer specialized radiology services in addition to treating leg vein disease. VCA's growth has provided new and challenging opportunities for our employees. Our company regularly promotes from within. As we add to our team, we recruit from within the communities that we serve. Working at Vein Clinics of America means working for a company whose mission is to help people. You can feel good about the work you do.

Tissue Regenix is a leading medical devices company in the field of regenerative medicine. Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds, UK. The company's patented decellularisation ('dCELL®') technology removes DNA and other cellular material from animal and human soft tissue leaving an acellular tissue scaffold which is not rejected by the patient's body and can then be used to repair diseased or worn out body parts. Current applications address many critical clinical needs such as sports medicine, heart valve replacement and wound care. In November 2012 Tissue Regenix Group plc set up a subsidiary company in the United States - 'Tissue Regenix Wound Care Inc.', rebranded 'TRX BioSurgery' in February 2018. January 2016 saw the establishment of joint venture GBM-V, a multi- tissue bank based in Rostock, Germany. In August 2017 Tissue Regenix acquired CellRight Technologies®, a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteoinductive and wound care scaffolds that enhance healing opportunities of defects created by trauma and disease. CellRight's human osteobiologics may be used in spine, trauma, general orthopedic, foot & ankle, dental, and sports medicine surgical procedures.

The world's largest cohesive physician group dedicated to practicing advanced orthobiologics